Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-12 of 12 for your search:
Drug:
selenium
Find trials that include:
Any drugs shown
Trial Status:
Active
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase III Randomized Chemoprevention Study of Selenium in Participants With Previously Resected Stage I Non-Small Cell Lung Cancer
Phase:
Phase III
Type:
Prevention
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
ECOG-5597
, CAN-NCIC-BR16, CALGB-79803, NCCTG-E5597, SWOG-E5597, NCI-P00-0176, NCT00008385, BR16
2.
Phase III Randomized Study of Selenium in Patients With Adenomatous Colorectal Polyps
Phase:
Phase III
Type:
Prevention
Status:
Active
Age:
40 to 80
Sponsor:
NCI
Protocol IDs:
UARIZ-00-0430-01
, 00-0430-01, UARIZ-HSC-00142, NCT00078897
3.
Phase III Study of the Effect of Vitamin E and/or Selenium on Adenomatous Colorectal Polyps in Men Enrolled on SELECT Trial SWOG-S0000
Phase:
Phase III
Type:
Natural history/Epidemiology, Prevention
Status:
Active
Age:
50 and over
Sponsor:
NCI
Protocol IDs:
SWOG-S0000D
, S0000D, NCT00706121
4.
Phase III Randomized Study of Selenium in Patients With Non-Muscle-Invasive Transitional Cell Carcinoma of the Bladder at Risk for Recurrence
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
UZG-CUL-UHG-Non-Invasive Bladder Cancer
, CUL-UHG-Non-Invasive Bladder Cancer, EU-20870, NCT00729287
5.
The Use of Selenium to Treat Secondary Lymphedema - Breast Cancer
Phase:
Phase II
Type:
Supportive care
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
UHN REB 03-0741-C
, NCT00188604
6.
Dietary Intervention in Follicular Lymphoma
Phase:
Phase II
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
Dietary intervention FL
, NCT00455416
7.
Study of Antioxidants on MRI Detectable Early Stage Prostate Cancer Among Men on Active Surveillance
Phase:
Phase II
Type:
Biomarker/Laboratory analysis, Diagnostic, Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
07-0580-B
, NCT00744549
8.
Phase II Randomized Study of Selenium in Patients With Adenocarcinoma of the Prostate
Phase:
Phase II
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
Under 85
Sponsor:
NCI
Protocol IDs:
UARIZ-97-0395
, UARIZ-HSC-97-57, Watchful Waiting, NCT00752739
9.
Study of Antioxidants on Prostate Tumors in Men Undergoing Radical Prostatectomy for Prostate Cancer
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
08-0604-CE
, NCT00844792
10.
Selenium and Prostate Cancer: Clinical Trial on Availability to Prostate Tissue and Effects on Gene Expression
Phase:
No phase specified
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
Not specified
Sponsor:
Other
Protocol IDs:
WCRF 2004/21
, CMO nr. 2007/003, SePros 2006/02, NL14694.091.07, NCT00446901
11.
PREADVISE Ancillary Study of Vitamin E and/or Selenium for the Prevention of Alzheimer's Disease in Older Men Enrolled on SELECT Clinical Trial SWOG-S0000 (Prostate Cancer Prevention Study)
Phase:
No phase specified
Type:
Natural history/Epidemiology
Status:
Active
Age:
60 and over
Sponsor:
NCI
Protocol IDs:
SWOG-S0000A
, S0000A, NCT00780689
12.
Ancillary Study of Vitamin E and/or Selenium for the Prevention of Cataract and Age-Related Macular Degeneration in Older Men Enrolled on SELECT Clinical Trial SWOG-S0000 (Prostate Cancer Prevention Study)
Phase:
No phase specified
Type:
Natural history/Epidemiology
Status:
Active
Age:
55 and over (50 and over for African Americans)
Sponsor:
NCI
Protocol IDs:
SWOG-S0000B
, S0000B, NCT00784225
Select All on Page
Help with Results
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute
